VSSP

2 trials

Sponsors

Center of Molecular Immunology (CIM)

Conditions

Renal cell carcinomametastatic renal carcinoma Adjuvants, Immunologic Immunomodulating Agents Vaccines Injections, Subcutaneous

Early Phase 1

VSSP in renal cell carcinoma

Active, not recruitingRPCEC00000365

Center of Molecular Immunology (CIM)Renal cell carcinoma

Start: 2011-11-29Target: 15Updated: 2026-03-30

Phase 2

VSSPs in renal carcinoma.

Active, not recruitingRPCEC00000425

Center of Molecular Immunology (CIM)metastatic renal carcinoma Adjuvants, Immunologic Immunomodulating Agents Vaccines Injections, Subcutaneous

Start: 2023-06-20Target: 70Updated: 2026-03-30